ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 200 filers reported holding ARGENX SE in Q1 2022. The put-call ratio across all filers is 0.51 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $31,660,972 | +26.1% | 64,400 | 0.0% | 6.98% | +48.6% |
| Q2 2023 | $25,098,612 | +4.6% | 64,400 | 0.0% | 4.69% | +0.5% |
| Q1 2023 | $23,994,152 | +5.0% | 64,400 | +6.8% | 4.67% | -11.4% |
| Q4 2022 | $22,843,449 | +7.3% | 60,300 | 0.0% | 5.27% | +7.9% |
| Q3 2022 | $21,289,000 | -6.8% | 60,300 | 0.0% | 4.89% | -8.3% |
| Q2 2022 | $22,846,000 | +3.7% | 60,300 | -13.7% | 5.33% | -1.9% |
| Q1 2022 | $22,040,000 | +1.0% | 69,900 | +12.1% | 5.43% | +2.1% |
| Q4 2021 | $21,828,000 | +34.8% | 62,332 | +16.2% | 5.32% | +3.5% |
| Q3 2021 | $16,197,000 | +1.1% | 53,632 | +0.8% | 5.14% | -6.6% |
| Q2 2021 | $16,027,000 | +36.5% | 53,232 | +24.9% | 5.50% | +19.3% |
| Q1 2021 | $11,740,000 | +103.8% | 42,632 | +117.7% | 4.61% | +25.1% |
| Q4 2020 | $5,760,000 | – | 19,587 | – | 3.68% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 297,701 | $112,778,070 | 70.21% |
| Artia Global Partners LP | 85,204 | $32,277,831 | 12.30% |
| Avoro Capital Advisors LLC | 1,265,555 | $479,430,201 | 7.16% |
| DCF Advisers, LLC | 25,000 | $9,470,750 | 6.40% |
| Eagle Health Investments LP | 60,300 | $22,843,449 | 5.27% |
| Avidity Partners Management LP | 625,000 | $236,768,750 | 5.13% |
| Bellevue Group AG | 911,100 | $345,152,013 | 4.58% |
| Fairmount Funds Management LLC | 73,526 | $27,853,855 | 4.42% |
| Paradigm Biocapital Advisors LP | 89,556 | $33,926,499 | 3.98% |
| RTW INVESTMENTS, LP | 482,195 | $182,669,932 | 3.73% |